Macrogenics shares are trading higher after Barclays upgraded the stock from Underweight to Overweight and raised its price target from $14 to $40 per share.
Macrogenics shares are trading higher after Barclays upgraded the stock from Underweight to Overweight and raised its price target from $14 to $40 per share.
在巴克莱(Barclays)将MacroGenics股票从减持上调至增持，并将目标价从每股14美元上调至40美元后，MacroGenics的股价上涨。
Macrogenics shares are trading higher after Barclays upgraded the stock from Underweight to Overweight and raised its price target from $14 to $40 per share.
Macrogenics shares are trading higher after Barclays upgraded the stock from Underweight to Overweight and raised its price target from $14 to $40 per share.
在巴克莱(Barclays)将MacroGenics股票从减持上调至增持，并将目标价从每股14美元上调至40美元后，MacroGenics的股价上涨。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
风险及免责提示
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
风险及免责提示
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧
点击这里分享给好友
暂无评论，快来抢沙发吧！